Related Experiment Videos
[A comparative evaluation between streptokinase and r-TPA in limiting the myocardial damage during an acute
S Morelloni1, L Fasciolo, V Freggiaro
1Servizio di Cardiologia, Ospedale S. Giacomo, Novi Ligure.
Insights
This study compared streptokinase and recombinant tissue plasminogen activator (r-TPA) for acute myocardial infarction. Echocardiography showed no significant difference between the drugs in limiting myocardial damage or improving left ventricular function.
Area of Science:
- Cardiology
- Pharmacology
Background:
- The choice of fibrinolytic agent after the GISSI I trial remained unclear.
- Acute myocardial infarction (AMI) management requires effective reperfusion strategies.
Purpose of the Study:
- To compare the efficacy of streptokinase versus recombinant tissue plasminogen activator (r-TPA) in limiting myocardial damage in AMI patients.
- To assess the impact of these fibrinolytic agents on left ventricular contractility.
Main Methods:
- Echocardiography was utilized to evaluate cardiac function and infarct size.
- A cohort of 33 patients with AMI, with an average age of 64.6 years, participated in the study.
Main Results:
- No statistically significant differences were observed between streptokinase and r-TPA regarding left ventricular contractility.
- The extent of the infarcted region showed no significant difference between the treatment groups.
Conclusions:
- Both streptokinase and r-TPA demonstrated comparable efficacy in limiting myocardial damage in AMI.
- Findings align with previous research, such as the Italian PAIMS study, suggesting similar outcomes for these agents.
Abstract:
Once the experience of GISSI I was concluded, the as yet unresolved problem of the choice of one fibrinolytic agent in preference to others emerged. In the present study, the authors used echocardiography in order to compare streptokinase with r-TPA in order to limit myocardial damage in acute myocardial infarction in 33 patients, average age 64.6 years. No statistically significant difference between the two drugs was observed as far as left ventricular contractility and extent of the infarcted region was concerned. This was in accordance with the findings of the Italian PAIMS study.